national chlamydia coalition 2010 evaluation

11
Victoria Beltran, DSTDP/HSREB Sonal R. Doshi, DSTDP/HSREB National Chlamydia Coalition Meeting October 28, 2010 National Chlamydia Coalition 2010 Evaluation Division of STD Prevention National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention 1

Upload: national-chlamydia-coalition

Post on 15-Jan-2015

936 views

Category:

Health & Medicine


2 download

DESCRIPTION

Presented by Sonal Doshi, Health Scientist, Division of STD Prevention, Centers for Disease Control and Prevention, and Victoria Beltran, ORISE Fellow, Division of STD Prevention, Centers for Disease Control and Prevention, at the 2010 National Chlamydia Coalition meeting.

TRANSCRIPT

Page 1: National Chlamydia Coalition 2010 Evaluation

Victoria Beltran, DSTDP/HSREBSonal R. Doshi, DSTDP/HSREB

National Chlamydia Coalition MeetingOctober 28, 2010

National Chlamydia Coalition 2010 Evaluation

Division of STD Prevention

National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention 1

Page 2: National Chlamydia Coalition 2010 Evaluation

Overview

Background Purpose Methods

CDC Evaluation Framework Evaluation Sub-Committee Evaluation Focus Timeline

Where We Are Now Next Steps

2

Page 3: National Chlamydia Coalition 2010 Evaluation

Background There is a movement towards increasing

use of coalitions in public health Few studies exist documenting

effectiveness of coalitions Fewer models exist to evaluate

effectiveness of coalition work in public health

No studies exist evaluating effectiveness of coalitions focused on STDs

3

Page 4: National Chlamydia Coalition 2010 Evaluation

Purpose Evaluate the effectiveness of the NCC,

including its internal operations and impact of the coalition on members and other stakeholders Document key factors that have contributed to NCC’s

success Document the process of coalition development so that

lessons learned can be used for developing future coalitions

Highlight strengths and accomplishments of NCC to inform for example, additional potential funders, internal and external to CDC

4

Page 5: National Chlamydia Coalition 2010 Evaluation

Methods: CDC Evaluation Framework

Centers for Disease Control and Prevention.  Framework for Program Evaluation in Public Health. MMWR 1999;48(No. RR-11).

5

Page 6: National Chlamydia Coalition 2010 Evaluation

Methods: Evaluation Sub-committee

NCCKeith Barton, MD

Policy and Advocacy Committee

Gail Burstein, MD, MPH, FAAP Provider Education CommitteeResearch Committee*

Yvonne Hamby, MPH Public Awareness Committee

Karen Shea, WHNP-BC Provider Education Committee

Partnership for Prevention

Christianne Johnson, MA, CHESSusan Maloney, MHSAlana Ward, MPP, MST

CDC/DSTDP StaffVictoria Beltran, MPH, CHESSonal R. Doshi, MS, MPHPenny Loosier, MA, MPHRaul Romaguera, DMD, MPH

* Requests for subcommittee volunteers was prior to Research Committee formation

6

Page 7: National Chlamydia Coalition 2010 Evaluation

Methods: Evaluation Focus

Process evaluation: document whether a program has been implemented as intended—“implementation fidelity”— and why or why not? To document the level of success in achieving objectives To identify areas of the program that need improvement To improve the content of the program’s materials To solicit more funds or additional partners

http://www.cdc.gov/eval/evalguide.pdf

7

Page 8: National Chlamydia Coalition 2010 Evaluation

Methods: Timeline

8

Page 9: National Chlamydia Coalition 2010 Evaluation

Where We Are Now

Member survey is open on Zoomerang Open until MONDAY NOVEMBER 1, 2010

Recruit participants for interviews Conduct phone interviews with select members in

November

9

Page 10: National Chlamydia Coalition 2010 Evaluation

Next Steps

Analyze member survey results Conduct phone interviews

Analyze results Complete final version of logic model Prepare evaluation report for subcommittee

feedback Revise as necessary

10

Page 11: National Chlamydia Coalition 2010 Evaluation

For more information please contact Centers for Disease Control and Prevention1600 Clifton Road NE, Atlanta, GA 30333Telephone, 1-800-CDC-INFO (232-4636)/TTY: 1-888-232-6348E-mail: [email protected] Web: www.cdc.gov

The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Thank you!Questions? Comments?

For more information, please contact: Sonal R. Doshi Victoria Beltran

[email protected] or [email protected] 404-639-6209 404-639-8270

National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention

Division of STD Prevention 11